IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
April 18, 2024 08:30 ET
|
Imunon, Inc.
Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc....